Bottom line
SHDRX vs APSDX: the short answer
SHDRX (American Beacon Shapiro SMID Cap Equity Fund) and APSDX (NYLI Fiera SMID Growth Fund) are both mutual funds.
APSDX is cheaper at 0.82% vs 0.9% — a difference of $8.00 a year per $10,000 invested.
Over one year, APSDX returned +5.8% vs −1.3% for SHDRX (reporting dates differ).
Updated Nov 19, 2026
SHDRX vs APSDX side by side
| SHDRX | APSDX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | ARK Invest | New York Life Investments |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.9% | 0.82% |
| Annual cost per $10k | $90 | $82 |
| 10-yr cost on $10k (prospectus) | $1,595 | $1,014 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −1.3% | +5.8% |
| 5-yr return (annualized) | +7.1% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | — | $201.4M |
| Number of holdings | — | 79 |
| Portfolio turnover | 67% | 5% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
SHDRX and APSDX share none of their top holdings.
SHDRX top 10
APSDX top 10
- JFrog Ltd. — 3.71%
- BWX Technologies, Inc. — 2.63%
- EMCOR Group, Inc. — 2.40%
- Neurocrine Biosciences, Inc. — 2.27%
- Stifel Financial Corp. — 2.23%
- MongoDB, Inc. — 2.12%
- Argenx SE — 2.09%
- Insmed, Inc. — 2.04%
- Expedia Group, Inc. — 2.00%
- Lattice Semiconductor Corp. — 1.97%
FAQ
What is the difference between SHDRX and APSDX?
SHDRX (American Beacon Shapiro SMID Cap Equity Fund) and APSDX (NYLI Fiera SMID Growth Fund) are both mutual funds. APSDX is cheaper at 0.82% vs 0.9% — a difference of $8.00 a year per $10,000 invested.
Which is cheaper, SHDRX or APSDX?
APSDX has the lower expense ratio (0.82%).
Should I own both SHDRX and APSDX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.